You are here:
Implanon NXT®: Possible risks and complications associated with insertion, localisation, removal and migration
2016.06.27
Active substance: etonogestrel
The company MSD Sharp & Dohme GmbH recommends that only those physicians should insert and remove Implanon NXT® who have completed training for the use of the NXT® applicator and techniques for insertion and removal of the Implanon NXT® implant.
Download DHPC/Information letter , Download_VeroeffentlichtAm_EN